Search

1 to 10 of 194
Sort by

Library Entry
Fight Colorectal Cancer - Liquid Biopsies, Next Generation Sequencing, ctDNA, and cfDNA

By now, it’s likely that you’ve heard the terms ctDNA, cfDNA, Next Generation Sequencing (NGS) and liquid biopsies thrown around, and with many acronyms and various test types out there for colorectal cancer, it can become confusing to understand how they can impact treatment and care. You can...


Library Entry
COVID-19 Vaccine FAQs for People with Cancer

View the most important information about the COVID-19 vaccines complied by LUNGevity. #WebPage #CollaborativePartner #LUNGevity #Patient #PatientAdvocate #2021


Library Entry
LUNGevity - Small Cell Lung Cancer Booklet

LUNGevity has developed a comprehensive series of materials for lung cancer patients and their caregivers, focused on understanding how lung cancer develops, how it can be diagnosed, and treatment options. Whether you or someone you care about has been diagnosed with lung cancer, or is concerned...

2 attachments



Event
36th Annual Meeting & Pre-Conference Programs (SITC 2021)

The Society for Immunotherapy of Cancer’s (SITC) 36 th Annual Meeting & Pre-Conference Programs (SITC 2021) will take place on Nov. 10–14, 2021, at the Walter E. Washington Convention Center in Washington, D.C. Registration and other details will be announced soon! Thank You to Our...

 11-10-2021 08:00 - 11-14-2021 12:00 ET
 Washington DC


Library Entry
Understanding Cancer Immunotherapy: Sixth Edition - A Patient Resource Guide

Your immune system is a powerful protection mechanism that works around the clock to defend you from harmful germs and internal stresses to normal cells in the body. After years of research, doctors have found a way to unleash its cancer-fighting potential, too. Immunotherapy harnesses the power...

2020 Immunotherapy.pdf


Library Entry
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

Immuno-oncologics (IOs) differ from chemotherapies as they prime the patient’s immune system to attack the tumor, rather than directly destroying cancer cells. The IO mechanism of action leads to durable responses and prolonged survival in some patients. However, providing robust evidence of the...